349 related articles for article (PubMed ID: 24252844)
1. The peroxisome proliferator activated receptor-γ pioglitazone improves vascular function and decreases disease activity in patients with rheumatoid arthritis.
Marder W; Khalatbari S; Myles JD; Hench R; Lustig S; Yalavarthi S; Parameswaran A; Brook RD; Kaplan MJ
J Am Heart Assoc; 2013 Nov; 2(6):e000441. PubMed ID: 24252844
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor γ agonist effect on rheumatoid arthritis: a randomized controlled trial.
Ormseth MJ; Oeser AM; Cunningham A; Bian A; Shintani A; Solus J; Tanner S; Stein CM
Arthritis Res Ther; 2013; 15(5):R110. PubMed ID: 24020899
[TBL] [Abstract][Full Text] [Related]
3. Reversing vascular dysfunction in rheumatoid arthritis: improved augmentation index but not endothelial function with peroxisome proliferator-activated receptor γ agonist therapy.
Ormseth MJ; Oeser AM; Cunningham A; Bian A; Shintani A; Solus J; Tanner SB; Stein CM
Arthritis Rheumatol; 2014 Sep; 66(9):2331-8. PubMed ID: 24782291
[TBL] [Abstract][Full Text] [Related]
4. Tetrahydrobiopterin Supplementation Improves Endothelial Function But Does Not Alter Aortic Stiffness in Patients With Rheumatoid Arthritis.
Mäki-Petäjä KM; Day L; Cheriyan J; Hall FC; Östör AJ; Shenker N; Wilkinson IB
J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26896473
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor-gamma activation with pioglitazone improves endothelium-dependent dilation in nondiabetic patients with major cardiovascular risk factors.
Campia U; Matuskey LA; Panza JA
Circulation; 2006 Feb; 113(6):867-75. PubMed ID: 16461819
[TBL] [Abstract][Full Text] [Related]
6. Advanced glycation end-products inhibition improves endothelial dysfunction in rheumatoid arthritis.
Syngle A; Vohra K; Garg N; Kaur L; Chand P
Int J Rheum Dis; 2012 Feb; 15(1):45-55. PubMed ID: 22324946
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Treatments for Rheumatoid Arthritis on Endothelial Dysfunction Evaluated by Flow-Mediated Vasodilation in Patients with Rheumatoid Arthritis.
Kotani K; Miyamoto M; Ando H
Curr Vasc Pharmacol; 2017; 15(1):10-18. PubMed ID: 27739363
[TBL] [Abstract][Full Text] [Related]
8. Effects of adalimumab treatment on vascular disease associated with early rheumatoid arthritis.
Kerekes G; Soltész P; Szucs G; Szamosi S; Dér H; Szabó Z; Csáthy L; Váncsa A; Szodoray P; Szegedi G; Szekanecz Z
Isr Med Assoc J; 2011 Mar; 13(3):147-52. PubMed ID: 21608334
[TBL] [Abstract][Full Text] [Related]
9. Effects of the Peroxisome Proliferator-Activated Receptor-γ Agonist Pioglitazone on Peripheral Vessel Function and Clinical Parameters in Nondiabetic Patients: A Double-Center, Randomized Controlled Pilot Trial.
Christoph M; Herold J; Berg-Holldack A; Rauwolf T; Ziemssen T; Schmeisser A; Weinert S; Ebner B; Ibrahim K; Strasser RH; Braun-Dullaeus RC
Cardiology; 2015; 131(3):165-71. PubMed ID: 25967848
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 17 as a novel predictor of vascular function in rheumatoid arthritis.
Marder W; Khalatbari S; Myles JD; Hench R; Yalavarthi S; Lustig S; Brook R; Kaplan MJ
Ann Rheum Dis; 2011 Sep; 70(9):1550-5. PubMed ID: 21727237
[TBL] [Abstract][Full Text] [Related]
11. PPARγ activation does not affect endothelin activity in non-diabetic patients with hypertension or hypercholesterolemia.
Campia U; Matuskey LA; Tesauro M; Cardillo C; Panza JA
Atherosclerosis; 2014 Jun; 234(2):436-40. PubMed ID: 24769306
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the PPAR-γ Agonist Pioglitazone in Mild Asthma: A Double-Blind Randomized Controlled Trial.
Anderson JR; Mortimer K; Pang L; Smith KM; Bailey H; Hodgson DB; Shaw DE; Knox AJ; Harrison TW
PLoS One; 2016; 11(8):e0160257. PubMed ID: 27560168
[TBL] [Abstract][Full Text] [Related]
13. Short-term pioglitazone treatment improves vascular function irrespective of metabolic changes in patients with type 2 diabetes.
Martens FM; Visseren FL; de Koning EJ; Rabelink TJ
J Cardiovasc Pharmacol; 2005 Dec; 46(6):773-8. PubMed ID: 16306801
[TBL] [Abstract][Full Text] [Related]
14. Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis.
Mäki-Petäjä KM; Booth AD; Hall FC; Wallace SM; Brown J; McEniery CM; Wilkinson IB
J Am Coll Cardiol; 2007 Aug; 50(9):852-8. PubMed ID: 17719471
[TBL] [Abstract][Full Text] [Related]
15. Effects of 1-year anti-TNF-α therapy on vascular function in rheumatoid arthritis and ankylosing spondylitis.
Végh E; Kerekes G; Pusztai A; Hamar A; Szamosi S; Váncsa A; Bodoki L; Pogácsás L; Balázs F; Hodosi K; Domján A; Szántó S; Nagy Z; Szekanecz Z; Szűcs G
Rheumatol Int; 2020 Mar; 40(3):427-436. PubMed ID: 31848735
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor gamma agonist improves arterial stiffness in patients with type 2 diabetes mellitus and coronary artery disease.
Yu J; Jin N; Wang G; Zhang F; Mao J; Wang X
Metabolism; 2007 Oct; 56(10):1396-401. PubMed ID: 17884451
[TBL] [Abstract][Full Text] [Related]
17. Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy.
Mäki-Petäjä KM; Hall FC; Booth AD; Wallace SM; Yasmin ; Bearcroft PW; Harish S; Furlong A; McEniery CM; Brown J; Wilkinson IB
Circulation; 2006 Sep; 114(11):1185-92. PubMed ID: 16952987
[TBL] [Abstract][Full Text] [Related]
18. Depletion of B-cells with rituximab improves endothelial function and reduces inflammation among individuals with rheumatoid arthritis.
Hsue PY; Scherzer R; Grunfeld C; Imboden J; Wu Y; Del Puerto G; Nitta E; Shigenaga J; Schnell Heringer A; Ganz P; Graf J
J Am Heart Assoc; 2014 Oct; 3(5):e001267. PubMed ID: 25336464
[TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory effects of pioglitazone and/or simvastatin in high cardiovascular risk patients with elevated high sensitivity C-reactive protein: the PIOSTAT Study.
Hanefeld M; Marx N; Pfützner A; Baurecht W; Lübben G; Karagiannis E; Stier U; Forst T
J Am Coll Cardiol; 2007 Jan; 49(3):290-7. PubMed ID: 17239709
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with change in arterial stiffness in patients with rheumatoid arthritis: the JointHeart study.
Linde A; Gerdts E; Fevang BT; Eilertsen RK; Kringeland E; Alsing CL; Midtbø H
Blood Press; 2024 May; 33(1):2353167. PubMed ID: 38824646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
